A first‐in‐human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release‐activated calcium (CRAC) channel modulator in healthy volunteers.
| Autor: | Barde, Prajak J.1, Viswanadha, Srikant1, Veeraraghavan, Sridhar1, Vakkalanka, Swaroop V.1, Nair, Ajit1 an@rhizen.com |
|---|---|
| Zdroj: | Journal of Clinical Pharmacy & Therapeutics. Jun2021, Vol. 46 Issue 3, p677-687. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|